Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial.
Di Cosimo S, Pérez-García JM, Bellet M, Dalenc F, Gil Gil MJ, Ruiz Borrego M, Gavilá J, Sampayo-Cordero M, Aguirre E, Schmid P, Marmé F, Gligorov J, Schneeweiss A, Albanell J, Zamora P, Wheatley D, Martínez-De Dueñas E, Carañana V, Amillano K, Mina L, Malfettone A, Cortés J, Llombart-Cussac A. Di Cosimo S, et al. Among authors: marme f. Oncologist. 2023 Jan 18;28(1):23-32. doi: 10.1093/oncolo/oyac205. Oncologist. 2023. PMID: 36239405 Free PMC article. Clinical Trial.
Personalized therapy in breast cancer.
Marmé F, Schneeweiss A. Marmé F, et al. Onkologie. 2012;35 Suppl 1:28-33. doi: 10.1159/000334973. Epub 2012 Jan 20. Onkologie. 2012. PMID: 22286585 Free article.
Predictors of resectability in breast-conserving therapy.
Rath MG, Heil J, Domschke C, Topic Z, Schneider S, Sinn HP, Marme F, Scharf A, Schneeweiss A, Sohn C, Rom J. Rath MG, et al. Among authors: marme f. Arch Gynecol Obstet. 2012 Oct;286(4):1023-31. doi: 10.1007/s00404-012-2401-8. Epub 2012 Jun 17. Arch Gynecol Obstet. 2012. PMID: 22707290
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.
Wallwiener M, Hartkopf AD, Baccelli I, Riethdorf S, Schott S, Pantel K, Marmé F, Sohn C, Trumpp A, Rack B, Aktas B, Solomayer EF, Müller V, Janni W, Schneeweiss A, Fehm TN. Wallwiener M, et al. Among authors: marme f. Breast Cancer Res Treat. 2013 Jan;137(2):503-10. doi: 10.1007/s10549-012-2382-0. Epub 2012 Dec 28. Breast Cancer Res Treat. 2013. PMID: 23271327 Clinical Trial.
CD24 polymorphisms in breast cancer: impact on prognosis and risk.
Buck K, Hug S, Seibold P, Ferschke I, Altevogt P, Sohn C, Schneeweiss A, Burwinkel B, Jäger D, Flesch-Janys D, Chang-Claude J, Marmé F. Buck K, et al. Among authors: marme f. Breast Cancer Res Treat. 2013 Feb;137(3):927-37. doi: 10.1007/s10549-012-2325-9. Epub 2013 Jan 13. Breast Cancer Res Treat. 2013. PMID: 23314606
Plasma microRNA panel for minimally invasive detection of breast cancer.
Cuk K, Zucknick M, Madhavan D, Schott S, Golatta M, Heil J, Marmé F, Turchinovich A, Sinn P, Sohn C, Junkermann H, Schneeweiss A, Burwinkel B. Cuk K, et al. Among authors: marme f. PLoS One. 2013 Oct 23;8(10):e76729. doi: 10.1371/journal.pone.0076729. eCollection 2013. PLoS One. 2013. PMID: 24194846 Free PMC article.
245 results